Shuji Hibiya

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Patients with inflammatory bowel disease (IBD) have an increased risk of developing colitis-associated colorectal cancer (CAC). CAC cells often develop chemoresistance, resulting in a poorer prognosis than that of sporadic colorectal cancer (CRC). The mechanism by which CAC enhances malignant potential remains unknown. We have previously reported that the(More)
  • 1